Skip to main content

Advertising Disclaimer »

Main menu

  • Journals
    • Pediatrics
    • Hospital Pediatrics
    • Pediatrics in Review
    • NeoReviews
    • AAP Grand Rounds
    • AAP News
  • Authors/Reviewers
    • Submit Manuscript
    • Author Guidelines
    • Reviewer Guidelines
    • Open Access
    • Editorial Policies
  • Content
    • Current Issue
    • Online First
    • Archive
    • Blogs
    • Topic/Program Collections
    • AAP Meeting Abstracts
  • Pediatric Collections
    • COVID-19
    • Racism and Its Effects on Pediatric Health
    • More Collections...
  • AAP Policy
  • Supplements
  • Multimedia
    • Video Abstracts
    • Pediatrics On Call Podcast
  • Subscribe
  • Alerts
  • Careers
  • Other Publications
    • American Academy of Pediatrics

User menu

  • Log in
  • My Cart

Search

  • Advanced search
American Academy of Pediatrics

AAP Gateway

Advanced Search

AAP Logo

  • Log in
  • My Cart
  • Journals
    • Pediatrics
    • Hospital Pediatrics
    • Pediatrics in Review
    • NeoReviews
    • AAP Grand Rounds
    • AAP News
  • Authors/Reviewers
    • Submit Manuscript
    • Author Guidelines
    • Reviewer Guidelines
    • Open Access
    • Editorial Policies
  • Content
    • Current Issue
    • Online First
    • Archive
    • Blogs
    • Topic/Program Collections
    • AAP Meeting Abstracts
  • Pediatric Collections
    • COVID-19
    • Racism and Its Effects on Pediatric Health
    • More Collections...
  • AAP Policy
  • Supplements
  • Multimedia
    • Video Abstracts
    • Pediatrics On Call Podcast
  • Subscribe
  • Alerts
  • Careers

Discover Pediatric Collections on COVID-19 and Racism and Its Effects on Pediatric Health

American Academy of Pediatrics
Research Briefs

Pediatric COVID-19 Cases Prelockdown and Postlockdown in Italy

Stefania Bellino, Maria Cristina Rota, Flavia Riccardo, Xanthi Andrianou, Alberto Mateo Urdiales, Martina Del Manso, Ornella Punzo, Antonino Bella, Alberto Villani, Patrizio Pezzotti and COVID-19 Working Group
Pediatrics February 2021, 147 (2) e2020035238; DOI: https://doi.org/10.1542/peds.2020-035238
Stefania Bellino
aDepartment of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria Cristina Rota
aDepartment of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Flavia Riccardo
aDepartment of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xanthi Andrianou
aDepartment of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alberto Mateo Urdiales
aDepartment of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy;
cEuropean Centre for Disease Prevention and Control, European Programme for Intervention Epidemiology Training, Stockholm, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martina Del Manso
aDepartment of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy;
cEuropean Centre for Disease Prevention and Control, European Programme for Intervention Epidemiology Training, Stockholm, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ornella Punzo
aDepartment of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Antonino Bella
aDepartment of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alberto Villani
bPediatric Emergency Department and General Pediatrics, Children Hospital Bambino Gesù, Rome, Italy; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patrizio Pezzotti
aDepartment of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • Comments
Loading
Download PDF
  • Abbreviation:
    COVID-19 —
    coronavirus disease 2019
  • In Italy, 15.8% of the residents are children <18 years old: specifically, 1.4% from 0 to 1 years of age, 4.1% from 2 to 6 years of age, 5.6% from 7 to 12 years of age, and 4.8% from 13 to 17 years of age. Fewer cases of coronavirus disease 2019 (COVID-19) have been reported in children <18 years of age than in adults.1 However, recent data indicate that the number and rate of pediatric cases are steadily increasing. During the lockdown phase, the incidence of COVID-19 was underestimated in children because of a lack of widespread testing and the priority of testing given to adults and patients with severe illness, whereas, now, the testing of mild and asymptomatic cases is leading to an increase in confirmed cases. The objective of the current study is to evaluate, before school starts, the impact of the transition phase (the progressive reopening of all activities starting from May 4 to September 13) of the epidemic on pediatric cases.

    Methods

    The study population included children <18 years of age with laboratory-confirmed COVID-19 (by reverse transcription polymerase chain reaction–based commercial diagnostic tests for severe acute respiratory syndrome coronavirus 2) reported to the Italian surveillance system until September 13, 2020,1 as per the case definition by the European Centre for Disease Prevention and Control.2 To identify the risk factors associated with the postlockdown phase, a multivariable logistic regression model was used, including sex, age groups (0–1, 2–6, 7–12, and 13–18 years), presence of pre-existing underlying medical conditions, severity of COVID-19 (considering the highest severity between baseline and follow-up), and geographic area of residency in Italy (Northwest, Northeast, Central, and South and Islands) as defined by the National Bureau of Census. The severity of the clinical state was defined as previously described.1 The transition from restrictive policies during the lockdown phase (February 23 to May 3) to a lockdown easing with a progressive reopening of all activities (May 4 to September 13) was decided at the national level and began in all parts of Italy simultaneously.

    Results

    As of September 13, 2020, 9868 pediatric COVID-19 cases have been reported in Italy, which represents 3.4% of all Italian cases. However, the rate of cases in children and adolescents has sharply increased since the beginning of the transition phase (May 4), from 1.8% during the lockdown to 8.5% (6197 of 73 206) during the postlockdown phase. Considering all case patients <18 years of age, a first peak of the outbreak at the end of March was followed by a second peak starting from the last week of August to the middle of September (Fig 1). Most asymptomatic cases were detected in the second phase of the epidemic for all age groups. Starting from lockdown easing (May 4, 2020), most cases occurred in adolescents from the ages of 13 to 17 (2558; 41.3%), followed by those in children from the ages of 7 to 12 (1736; 28.0%), 2 to 6 (1303; 21.0%), and 0 to 1 (600; 9.7%). The hospitalization rate was 4.8%, and the highest percentage of hospital admission occurred in infants aged ≤1 year (16.2%), followed by children of older ages (∼3.5%); among hospitalized patients, the admission rate to the ICU was 4.3%. Underlying medical conditions were found in 2.8% of all cases and 5.3% of hospitalized patients. Asymptomatic and paucisymptomatic patients accounted for 71.2% and 8.4% of COVID-19 cases, respectively, whereas children with mild infections represented 18.5% of the pediatric population; subjects with a severe or critical infection were 2%. In this last group infants ≤1 year of age showed the highest proportion (7.2%), whereas the other age groups were just above 1%. Since June 3, when interregional movements and travels in the European Union area were allowed, ∼19% of cases (1001 of 5312) have been imported. Italian Northwest regions (Piemonte, Valle d’Aosta, Liguria, and Lombardia) reported 33.4% of total pediatric cases, followed by Northeast regions (30.8%), Central (16.6%), and South and Islands (19.3%). After adjusting for sex, age groups, underlying medical conditions, disease severity, and geographic area, children from the ages of 2 to 6 had a slightly higher risk of acquiring COVID-19 in the transition phase of the epidemic than infants ≤1 year of age, whereas a lower risk was associated with the presence of underlying medical conditions and symptoms (paucisymptomatic state, mild disease, severe or critical disease). Moreover, Italian Northeast, Central, and South and Island areas presented a lower risk, compared with the Northwest regions (Table 1).

    FIGURE 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1

    Epidemic curve by date of positive test result and disease severity (asymptomatic or symptomatic) of COVID-19 cases patients <18 years of age in Italy, from February 23 to September 13, 2020. A, 0–1 year. B, 2–6 years. C, 7–12 years. D, 13–17 years. Asymptomatic is shown in light blue, and symptomatic is shown in red.

    View this table:
    • View inline
    • View popup
    TABLE 1

    Risk Factors for Study Period (May 4 to September 13 versus February 23 to May 3, 2020) in Individuals <18 Years of Age in Italy; Multivariable Logistic Regression Model

    Discussion

    An increase of COVID-19 cases is being observed worldwide after the lifting of lockdowns as well as the relaxation of physical distancing and other preventive measures.3

    In Italy, increased testing has contributed to a better detection of ongoing transmission, and, to date, >2000 local outbreaks are ongoing throughout the country. Cases of COVID-19 in those <18 years of age started to increase just after the lockdown easing, as observed in the United States.4

    In the second phase of the epidemic, compared with the first one, the pediatric case distribution among age groups was similar, both hospitalizations and preexisting underlying medical conditions declined and asymptomatic patients increased, with fewer severe cases.1 Because children are more likely to have an asymptomatic or paucisymptomatic infection, compared with adults, pediatric cases may have been undetected or underestimated, altering the true proportion on the overall population, particularly during the peak of the epidemic,5 when only subjects with clear signs and symptoms of the disease were tested. However, with lockdown easing, the systematic contact tracing, including novel digital tracing approaches as well as widespread testing, allowed to detect more cases and identify groups at the highest risk of disease.6 Physical distancing, hand hygiene, facemasks, reducing contacts, and staying home when ill are essential measures for infection control, particularly with the reopening of schools, which are likely to have an impact on community transmission.

    The national surveillance system will continue to monitor the school reopening impact on the epidemiological trend, both locally and nationally, to inform and guide policymakers in different evaluation strategies, weighing the risk of exposing students and staff to COVID-19 with the benefits of in-person school.

    Acknowledgments

    The COVID-19 working group members were as follows: Massimo Fabiani, Stefano Boros, Maria Fenicia Vescio, Matteo Spuri, Antonietta Filia, Paolo D’Ancona, Andrea Siddu, Roberta Urciuoli, Stefania Giannitelli, Paola Stefanelli, Alessandra Ciervo, Corrado Di Benedetto, Marco Tallon, (Istituto Superiore di Sanità); Regional representatives - Manuela Di Giacomo (Abruzzo), Michele La Bianca (Basilicata), Anna Domenica Mignuoli (Calabria), Angelo D'Argenzio (Campania), Erika Massimiliani (Emilia-Romagna), Tolinda Gallo (Friuli Venezia Giulia), Francesco Vairo (Lazio), Camilla Sticchi (Liguria), Danilo Cereda (Lombardia), Daniel Fiacchini (Marche), Francesco Sforza (Molise), Maria Grazia Zuccaro (P.A. Bolzano), Pier Paolo Benetollo (P.A. Trento), Daniela Tiberti (Piemonte), Maria Chironna (Puglia), Maria Antonietta Palmas (Sardegna), Salvatore Scondotto (Sicilia), Lucia Pecori (Toscana), Anna Tosti (Umbria), Mauro Ruffier (Valle D’Aosta); Filippo Da Re (Veneto).

    We thank all local health personnel involved in the COVID-19 outbreak.

    Footnotes

      • Accepted November 2, 2020.
    • Address correspondence to Stefania Bellino, PhD, Department of Infectious Diseases, Istituto Superiore di Sanità, viale Regina Elena, 299, 00161 Rome, Italy. E-mail: stefania.bellino{at}iss.it
    • FINANCIAL DISCLOSURE: The authors have indicated they have no financial relationships relevant to this article to disclose.

    • FUNDING: Routine institutional funding was used to perform this work.

    • POTENTIAL CONFLICT OF INTEREST: The authors have indicated they have no potential conflicts of interest to disclose.

    References

    1. 1.↵
      1. Bellino S,
      2. Punzo O,
      3. Rota MC, et al.; COVID-19 Working Group
      . COVID-19 disease severity risk factors for pediatric patients in Italy. Pediatrics. 2020;146(4):e2020009399
      OpenUrlAbstract/FREE Full Text
    2. 2.↵
      1. European Centre for Disease Prevention and Control
      . Case definition for coronavirus 2019 (COVID-19), as of 29 May 2020. Available at: https://www.ecdc.europa.eu/en/covid-19/surveillance/case-definition. Accessed December 21, 2020
    3. 3.↵
      1. European Centre for Disease Prevention and Control
      . COVID-19 situation update worldwide, as of week 50 2020. Available at: https://www.ecdc.europa.eu/en/geographical-distribution-2019-ncov-cases. Accessed December 21, 2020
    4. 4.↵
      Centers for Disease Control and Prevention. Information for pediatric healthcare providers. Available at: https://www.cdc.gov/coronavirus/2019-ncov/hcp/pediatric-hcp.html. Accessed August 19, 2020
    5. 5.↵
      European Centre for Disease Prevention and Control. COVID-19 in children and the role of school settings in COVID-19 transmission. Available at: https://www.ecdc.europa.eu/en/publications-data/children-and-school-settings-covid-19-transmission. Accessed August 6, 2020
    6. 6.↵
      1. Italian Ministry of Health
      . Ricerca e gestione dei contatti di casi COVID-19 (contact tracing) ed App Immuni. Available at: www.anci.it/wp-content/uploads/Circolare-COVID19_contact_tracing.pdf. Accessed December 21, 2020
    • Copyright © 2021 by the American Academy of Pediatrics
    PreviousNext
    Back to top

    Advertising Disclaimer »

    In this issue

    Pediatrics
    Vol. 147, Issue 2
    1 Feb 2021
    • Table of Contents
    • Index by author
    View this article with LENS
    PreviousNext
    Email Article

    Thank you for your interest in spreading the word on American Academy of Pediatrics.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Pediatric COVID-19 Cases Prelockdown and Postlockdown in Italy
    (Your Name) has sent you a message from American Academy of Pediatrics
    (Your Name) thought you would like to see the American Academy of Pediatrics web site.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Request Permissions
    Article Alerts
    Log in
    You will be redirected to aap.org to login or to create your account.
    Or Sign In to Email Alerts with your Email Address
    Citation Tools
    Pediatric COVID-19 Cases Prelockdown and Postlockdown in Italy
    Stefania Bellino, Maria Cristina Rota, Flavia Riccardo, Xanthi Andrianou, Alberto Mateo Urdiales, Martina Del Manso, Ornella Punzo, Antonino Bella, Alberto Villani, Patrizio Pezzotti, COVID-19 Working Group
    Pediatrics Feb 2021, 147 (2) e2020035238; DOI: 10.1542/peds.2020-035238

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    Share
    Pediatric COVID-19 Cases Prelockdown and Postlockdown in Italy
    Stefania Bellino, Maria Cristina Rota, Flavia Riccardo, Xanthi Andrianou, Alberto Mateo Urdiales, Martina Del Manso, Ornella Punzo, Antonino Bella, Alberto Villani, Patrizio Pezzotti, COVID-19 Working Group
    Pediatrics Feb 2021, 147 (2) e2020035238; DOI: 10.1542/peds.2020-035238
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
    Print
    Download PDF
    Insight Alerts
    • Table of Contents

    Jump to section

    • Article
      • Methods
      • Results
      • Discussion
      • Acknowledgments
      • Footnotes
      • References
    • Figures & Data
    • Info & Metrics
    • Comments

    Related Articles

    • No related articles found.
    • PubMed
    • Google Scholar

    Cited By...

    • No citing articles found.
    • Google Scholar

    More in this TOC Section

    • HPV Vaccine Recommendations and Parental Intent
    • Marijuana Use to Address Symptoms and Side Effects by Youth With Chronic Medical Conditions
    Show more Research Briefs

    Similar Articles

    Subjects

    • Public Health
      • Public Health
    • Infectious Disease
      • Infectious Disease
      • Epidemiology
    • Journal Info
    • Editorial Board
    • Editorial Policies
    • Overview
    • Licensing Information
    • Authors/Reviewers
    • Author Guidelines
    • Submit My Manuscript
    • Open Access
    • Reviewer Guidelines
    • Librarians
    • Institutional Subscriptions
    • Usage Stats
    • Support
    • Contact Us
    • Subscribe
    • Resources
    • Media Kit
    • About
    • International Access
    • Terms of Use
    • Privacy Statement
    • FAQ
    • AAP.org
    • shopAAP
    • Follow American Academy of Pediatrics on Instagram
    • Visit American Academy of Pediatrics on Facebook
    • Follow American Academy of Pediatrics on Twitter
    • Follow American Academy of Pediatrics on Youtube
    • RSS
    American Academy of Pediatrics

    © 2021 American Academy of Pediatrics